Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:AFIBNASDAQ:TIVCNASDAQ:TTOONASDAQ:VERO On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeAFIBAcutus Medical$0.01+5,150.0%$0.04$0.00▼$0.22$313K-0.0936,456 shs29,311 shsTIVCTivic Health Systems$4.11-2.8%$4.25$2.43▼$16.08$3.61M2.03647,782 shs69,535 shsTTOOT2 Biosystems$0.16+4.1%$0.13$0.06▼$6.80$3.29M0.46592,004 shs126,547 shsVEROVenus Concept$2.28+2.7%$2.98$2.10▼$17.49$3.25M-0.03383,732 shs27,503 shsFree Today: Your Guide to Smarter Options TradesLearn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceAFIBAcutus Medical-98.18%-99.35%-99.56%-99.63%-99.61%TIVCTivic Health Systems-1.40%-2.08%-40.67%-45.84%-45.90%TTOOT2 Biosystems-5.59%+0.13%+23.20%-16.50%-97.33%VEROVenus Concept-2.20%0.00%-13.95%-34.92%-66.20%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationAFIBAcutus MedicalN/AN/AN/AN/AN/AN/AN/AN/ATIVCTivic Health Systems0.0175 of 5 stars0.02.00.00.00.00.00.0TTOOT2 BiosystemsN/AN/AN/AN/AN/AN/AN/AN/AVEROVenus Concept0.8598 of 5 stars0.04.00.00.01.03.30.0Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceAFIBAcutus Medical 0.00N/AN/AN/ATIVCTivic Health Systems 0.00N/AN/AN/ATTOOT2 Biosystems 2.00Hold$5.003,094.89% UpsideVEROVenus Concept 0.00N/AN/AN/ACurrent Analyst Ratings BreakdownCompare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookAFIBAcutus Medical$7.16M0.04N/AN/A($0.03) per share-0.35TIVCTivic Health Systems$516K6.99N/AN/A$2.44 per share1.68TTOOT2 Biosystems$7.68M0.43N/AN/A($6.91) per share-0.02VEROVenus Concept$64.83M0.05N/AN/A($2.43) per share-0.94Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateAFIBAcutus Medical-$81.66MN/A0.00∞N/A-272.74%-311.64%-11.57%N/ATIVCTivic Health Systems-$8.24MN/A0.00∞N/A-670.95%-201.30%-154.54%N/ATTOOT2 Biosystems-$50.08MN/A0.00∞N/A-563.16%N/A-174.06%5/29/2025 (Estimated)VEROVenus Concept-$37.25M-$76.30N/A∞N/A-74.62%N/A-47.46%8/11/2025 (Estimated)Latest AFIB, TTOO, VERO, and TIVC EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/15/2025Q1 2025TIVCTivic Health SystemsN/A-$2.52N/A-$2.52N/A$0.07 million5/15/2025Q1 2025VEROVenus Concept-$14.08-$17.44-$3.36-$17.44$14.59 million$13.64 million3/31/2025Q4 2024VEROVenus Concept-$10.0089-$11.23-$1.2211-$11.23$16.99 million$15.77 million3/21/2025Q4 2024TIVCTivic Health Systems-$85.00-$19.68+$65.32N/A$1.43 millionN/ACompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthAFIBAcutus MedicalN/AN/AN/AN/AN/ATIVCTivic Health SystemsN/AN/AN/AN/AN/ATTOOT2 BiosystemsN/AN/AN/AN/AN/AVEROVenus ConceptN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioAFIBAcutus MedicalN/A1.851.57TIVCTivic Health SystemsN/A5.654.34TTOOT2 BiosystemsN/A0.400.24VEROVenus Concept2.831.861.18Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipAFIBAcutus Medical56.91%TIVCTivic Health Systems4.25%TTOOT2 Biosystems23.18%VEROVenus Concept87.41%Insider OwnershipCompanyInsider OwnershipAFIBAcutus Medical5.21%TIVCTivic Health Systems0.31%TTOOT2 Biosystems0.03%VEROVenus Concept28.04%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableAFIBAcutus Medical34029.78 million28.23 millionOptionableTIVCTivic Health Systems10878,0009.44 millionNot OptionableTTOOT2 Biosystems18021.04 million21.04 millionOptionableVEROVenus Concept4101.42 million3.70 millionNot OptionableAFIB, TTOO, VERO, and TIVC HeadlinesRecent News About These CompaniesVenus Concept Announces First Quarter 2025 Financial ResultsMay 16, 2025 | theglobeandmail.comVenus Concept Inc (VERO) Q1 2025 Earnings Call Highlights: Navigating Revenue Declines Amid ...May 16, 2025 | finance.yahoo.comVenus Concept Inc. (NASDAQ:VERO) Q1 2025 Earnings Call TranscriptMay 16, 2025 | msn.comVenus Concept Inc. (VERO) Q1 2025 Earnings Call TranscriptMay 15, 2025 | seekingalpha.comVenus Concept Raises a Total of Approximately $2.7 Million in Gross Proceeds from Previously Announced Registered Direct Offerings of Common StockApril 14, 2025 | globenewswire.comVenus Concept prices 386,700 shares at $4.06 in registered direct offeringApril 11, 2025 | markets.businessinsider.comVenus Concept Announces $1.5 Million Registered Direct Offering of Common Stock Priced At-The-Market Under Nasdaq RulesApril 11, 2025 | globenewswire.comVenus Concept Announces Closing of $1.1 Million Registered Direct Offering of Common Stock Priced At-The-Market Under Nasdaq RulesApril 10, 2025 | globenewswire.comVenus Concept to sell 328,573 shares at $3.50 in registered direct offeringApril 9, 2025 | markets.businessinsider.comVenus Concept Shares Tripled On Wednesday: Here's What HappenedApril 9, 2025 | benzinga.comVenus Concept Announces $1.1 Million Registered Direct Offering of Common Stock Priced At-The-Market Under Nasdaq RulesApril 9, 2025 | globenewswire.comVenus Concept Announces $1.1 Million Registered Direct Offering of Common Stock Priced At-The-Market Under Nasdaq RulesApril 9, 2025 | globenewswire.comVenus Concept to Release First Quarter of Fiscal Year 2025 Financial Results on May 15, 2025April 7, 2025 | globenewswire.comVenus Concept announces $11M debt-to-equity exchange transactionApril 2, 2025 | markets.businessinsider.comVenus Concept Completes Debt-to-Equity Exchange with MadrynApril 2, 2025 | tipranks.comVenus Concept Announces $11 million Debt-to-Equity Exchange TransactionApril 1, 2025 | globenewswire.comVenus Concept Inc. (NASDAQ:VERO) Q4 2024 Earnings Call TranscriptApril 1, 2025 | msn.comVenus Concept reports Q4 EPS ($11.23) vs ($20.14) last yearApril 1, 2025 | markets.businessinsider.comVenus concept signals revenue stabilization as strategic shifts concludeMarch 31, 2025 | msn.comVenus Concept Inc. (VERO) Q4 2024 Earnings Conference Call TranscriptMarch 31, 2025 | seekingalpha.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeAFIB, TTOO, VERO, and TIVC Company DescriptionsAcutus Medical NASDAQ:AFIB$0.01 +0.01 (+5,150.00%) As of 03:09 PM EasternAcutus Medical, Inc. designs, manufactures, and markets various tools for catheter-based ablation procedures to treat various arrhythmias in the United States and internationally. Its product portfolio includes novel access sheaths, transseptal crossing tools, diagnostic and mapping catheters, conventional and contact ablation catheters, and mapping and imaging consoles and accessories, as well as supporting algorithms and software programs. Acutus Medical, Inc. was incorporated in 2011 and is headquartered in Carlsbad, California.Tivic Health Systems NASDAQ:TIVC$4.11 -0.12 (-2.84%) Closing price 04:00 PM EasternExtended Trading$4.19 +0.08 (+2.04%) As of 07:56 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Tivic Health Systems Inc. operates as a health tech company, focuses on developing and commercializing bioelectronic medicine. Its primary product is ClearUP, a bioelectronic medicine for the treatment of sinus and nasal inflammation. The company sells its products on direct-to-consumer channel through its own websites; and platforms, such as Amazon.com and Walmart.com, as well as to U.S. online retailers, such as BestBuy and FSAStore and through distributors. Tivic Health Systems, Inc. was incorporated in 2016 and is headquartered in Hayward, California.T2 Biosystems NASDAQ:TTOO$0.16 +0.01 (+4.13%) As of 03:44 PM EasternT2 Biosystems, Inc., an in vitro diagnostics company, develops and sells diagnostic products and product candidates in the United States and internationally. Its technology enables detection of pathogens, biomarkers, and other abnormalities in various unpurified patient sample types, including whole blood, plasma, serum, saliva, sputum, cerebral spinal fluid, and urine. The company also offers T2Dx Instrument, a bench-top instrument that runs various diagnostic tests from patient samples; T2Candida panel, a direct-from-blood molecular diagnostic test panel that detects lethal form of common blood stream infections, which cause sepsis and candidemia; T2Bacteria panel, a direct-from-blood molecular diagnostic test panel, which detects bacterial pathogens in blood stream infections; T2Resistance panel, a direct-from-blood test that identifies carbapenem resistance genes; and T2Biothreat, a direct-from-blood molecular diagnostic test panel that runs on the T2Dx Instrument and detects biothreat pathogens. In addition, it is developing T2Cauris panel, a direct-from-blood molecular diagnostic test that runs on the T2Dx Instrument and detects Candida auris; and T2Lyme panel, a direct-from-blood molecular diagnostic test panel that runs on the T2Dx Instrument to identify the bacteria that cause Lyme disease. T2 Biosystems, Inc. was incorporated in 2006 and is headquartered in Lexington, Massachusetts.Venus Concept NASDAQ:VERO$2.28 +0.06 (+2.70%) Closing price 04:00 PM EasternExtended Trading$2.27 -0.01 (-0.26%) As of 06:30 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Venus Concept Inc., a medical technology company, develops, commercializes, and delivers minimally invasive and non-invasive medical aesthetic and hair restoration technologies, and related services in the United States and internationally. Its product portfolio includes Venus Legacy, a noninvasive device used in dermatological and general surgical procedures for females; Venus Versa, a multi-application device used in aesthetic and cosmetic procedures; Venus Versa Pro; and Venus Viva and Venus Viva MD, an advanced, portable, and fractional RF system for dermatological procedures requiring ablation and resurfacing of the skin. The company also offers Venus Fiore, a device that delivers non-thermal RF with massage and magnetic field pulses to treat various medical conditions; Venus Bliss and Venus Bliss Max for non-invasive lipolysis of the abdomen, back, thights, and flanks in individuals with a body mass index of 30 or less; Venus Glow, a dermabrasion device used to improve skin appearance; and NeoGraft, an advanced hair restoration technology with an automated FUE and implantation system. In addition, it provides Venus Velocity and Venus Epileve for hair removal, permanent hair reduction, and treatment of pseudofolliculitis barbae; ARTAS iX, a robotic system to assist physicians in identifying and extracting hair follicles units from the scalp during hair transplantation, creating recipient sites, and implanting the harvested hair follicles; and AI.ME an interactive, image-guided, and computer assisted system for fractional skin resurfacing. The company is headquartered in Toronto, Canada. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Turbulence for Joby Shares: What's Behind the Recent Dip? Pfizer's 7.5% Dividend: Income Haven or House of Cards? TJX Stock Price Stumble Is Your Chance to Pick Up a Bargain Advance Auto Parts Jumps on Surprise Earnings Beat Costco Stock at $1K: Dominance or Danger Zone? Williams-Sonoma: A Fundamentally Good Buy On Sale Now Snowflake Breaks Out! Can It Drift Higher in 2025 and Beyond? Alphabet Gets JPMorgan’s Vote of Confidence After Google I/O Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
